Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription Articles published in Ann Thorac Surg Retrieve available abstracts of 168 articles: HTML format

Single Articles

November 2027
1. TUPPER HI, Shrager JB, Moghanaki D, Simone CB 2nd, et al
   Misinformation and Overestimation of Computed Tomography Lung Cancer Screening Harms - Methodology Matters: A Joint Statement from the Society of Thoracic Surgeons, the American Society for Radiation Oncology, and the American College of Radiology.
   Ann Thorac Surg. 2027 Nov 11:S0003-4975(25)01112.
   PubMed    
   
   
   August 2026
2. BRANDT WS, Eaton DB, Seyoum N, Thomas TS, et al
   Dropout after Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer in the Veterans Health Administration.
   Ann Thorac Surg. 2026 Aug 5:S0003-4975(26)00805.
   PubMed     Abstract available
   
   
   
3. MARTIN LW, Wang X, Kozono D, Urbanic J, et al
   CHIO3: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B (N2) Non-Small Cell Lung Cancer: Surgical Outcomes.
   Ann Thorac Surg. 2026 Aug 5:S0003-4975(26)00815.
   PubMed     Abstract available
   
   
   
4. KAMTAM DN, Bonnell LN, Kapula N, Engelhardt KE, et al
   A Society of Thoracic Surgeons General Thoracic Surgery Database Analysis of the Association Between Lymph Node Dissection and Chylothorax.
   Ann Thorac Surg. 2026;122:291-300.
   PubMed     Abstract available
   
   
   
5. XU Y, Wang Z, Pan H, Tan Q, et al
   Is Sublobar Resection Optimal for Peripheral Nodules
   Ann Thorac Surg. 2026;122:302-309.
   PubMed     Abstract available
   
   
   
6. NASRALLA A, Cypel M
   A Novel Approach for Resection of Centrally Located Metastatic Sarcoma to the Lung.
   Ann Thorac Surg. 2026;122:493-494.
   PubMed     Abstract available
   
   
   July 2026
7. BROAD SR, Wei J, Denson K, Shi Z, et al
   Association Between Rare Germline Variants in Cancer Susceptibility Genes and Lung Cancer Risk.
   Ann Thorac Surg. 2026 Jul 31:S0003-4975(26)00752.
   PubMed     Abstract available
   
   
   
8. GOCHI AM, Wang T, Kwak HV, Huang Perez AK, et al
   Risk of Primary Lung Cancer in Women with Personal History of Breast Cancer and Subsequent Treatment Modality in an Integrated Health System.
   Ann Thorac Surg. 2026 Jul 24:S0003-4975(26)00731.
   PubMed     Abstract available
   
   
   
9. VELOTTA JB, Roden AC, Rice J, Simone CB, et al
   The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma.
   Ann Thorac Surg. 2026;122:3-21.
   PubMed     Abstract available
   
   
   
10. LI H, Pezeshkian F, Sugarbaker E, Mazzola E, et al
    Optimal Margin for Sublobar Resection of Invasive Lung Adenocarcinoma Presenting as Mixed Ground-Glass Nodules.
    Ann Thorac Surg. 2026;122:159-168.
    PubMed     Abstract available
    
    
    
11. XU J, Wang K, Zhang G, Liu X, et al
    Surgical and Survival Benefits of Neoadjuvant Targeted Therapy vs Chemoimmunotherapy in Lung Adenocarcinoma: A Dual-Center Research.
    Ann Thorac Surg. 2026;122:170-177.
    PubMed     Abstract available
    
    
    
12. GULATI S, Wolf A, Mehrotra-Varma J, Tuminello S, et al
    Disaster on MARS2? Lessons Learned from Modern Day Outcomes of Surgery for Pleural Mesothelioma.
    Ann Thorac Surg. 2026;122:178-185.
    PubMed     Abstract available
    
    
    
13. COWAN BE, Xiao M, Gomes C, Laxmanan B, et al
    Atypical Histology in Pulmonary Biopsies Obtained Using Robotic-Assisted Bronchoscopy: Natural History and Clinical Practice.
    Ann Thorac Surg. 2026;122:186-193.
    PubMed     Abstract available
    
    
    June 2026
14. HOODA Z, Ries S, McCracken A, Carbone G, et al
    Outcomes of Lobectomy Versus Sublobar Resection for Clinical Stage IA3 Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2026 Jun 22:S0003-4975(26)00581.
    PubMed     Abstract available
    
    
    
15. KHULLAR OV, Kidane B, Altorki N, Antonoff M, et al
    STS Expert Consensus Document (2026) on Addressing Definition and Practices of Sublobar Resection in Non-small Cell Lung Cancer.
    Ann Thorac Surg. 2026 Jun 19:S0003-4975(26)00579.
    PubMed     Abstract available
    
    
    
16. TAJE R, Gallina FT, Spicer JD
    STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPY.
    Ann Thorac Surg. 2026 Jun 9:S0003-4975(26)00536.
    PubMed     Abstract available
    
    
    
17. POTTER AL, Wang D, Bonnell L, Jacobs RC, et al
    Comparing Nodal Upstaging Rates and Morbidity and Mortality of Common Nodal Sampling Guidelines in the STS General Thoracic Surgery Database.
    Ann Thorac Surg. 2026;121:1309-1317.
    PubMed     Abstract available
    
    
    
18. BAIU I, Altorki NK, Kneuertz PJ
    Wedge Resection for Early-Stage Non-Small Cell Lung Cancer: Are We There Yet?
    Ann Thorac Surg. 2026;121:1299-1308.
    PubMed     Abstract available
    
    
    
19. SERVAIS EL, Hayanga JWA, Linden P, Sood P, et al
    The Society of Thoracic Surgeons (2025) Expert Consensus Document on Interventions for Screen-Detected Lung Nodules.
    Ann Thorac Surg. 2026;121:1283-1297.
    PubMed     Abstract available
    
    
    May 2026
20. SERVAIS EL
    Conversion, Judgment, and Priorities in Post-Induction Lung Cancer Surgery.
    Ann Thorac Surg. 2026 May 6:S0003-4975(26)00428.
    PubMed    
    
    
    
21. BOSTOCK IC, Fox AH, Engelhardt KE, Huang K, et al
    Does This Lymph Node Look Bulky to You? What Should We Do About It? A Survey of Thoracic Surgeons.
    Ann Thorac Surg. 2026;121:1195-1201.
    PubMed     Abstract available
    
    
    
22. WATANABE Y, Uchida S, Hattori A, Fukui M, et al
    A Comparative Analysis of Nodal Spread in Solid-Predominant vs Pure-Solid Stage IA Hypometabolic Lung Adenocarcinoma.
    Ann Thorac Surg. 2026;121:1221-1229.
    PubMed     Abstract available
    
    
    April 2026
23. YOON DW, Shin DW, Jung J, Joh HS, et al
    Short- and Long-Term Risks of Atrial Fibrillation in Surgically Treated Lung Cancer Patients: A Korean Nationwide Study.
    Ann Thorac Surg. 2026 Apr 8:S0003-4975(26)00320.
    PubMed     Abstract available
    
    
    March 2026
24. POHLMAN A, Odeh B, Raad W, Lubawski J, et al
    Lobar versus Sub-lobar Lung Resection for Early-Stage Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2026 Mar 31:S0003-4975(26)00308.
    PubMed     Abstract available
    
    
    
25. VALDERRAMA A, Williams KM, Soe A, Velotta JB, et al
    Defining Surgical Timeliness as a Quality Metric in Early-Stage Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2026 Mar 14:S0003-4975(26)00226.
    PubMed    
    
    
    
26. RUSCH VW
    Optimizing lung cancer screening.
    Ann Thorac Surg. 2026 Mar 12:S0003-4975(26)00211.
    PubMed    
    
    
    
27. WANG S, Zhou Y, Hu S, Bian D, et al
    Neoadjuvant chemoimmunotherapy followed by surgery or radiotherapy for stage IIIA-B non-small cell lung cancer with bulky N2 disease.
    Ann Thorac Surg. 2026 Mar 5:S0003-4975(26)00199.
    PubMed     Abstract available
    
    
    
28. ZHAN PL, Canavan ME, Bader JM, Boffa DJ, et al
    Prolonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis.
    Ann Thorac Surg. 2026;121:633-642.
    PubMed     Abstract available
    
    
    February 2026
29. XU W, Li Z, Zheng J, Pan X, et al
    Subsegment-based versus segment-based anatomical sublobar resection for lung cancer: A propensity score-matched analysis.
    Ann Thorac Surg. 2026 Feb 17:S0003-4975(26)00140.
    PubMed     Abstract available
    
    
    
30. MCCRACKEN AL, Antonoff MB
    When Access Is Standardized, Outcomes Converge in Early-Stage Lung Cancer.
    Ann Thorac Surg. 2026 Feb 13:S0003-4975(26)00131.
    PubMed    
    
    
    
31. LIBERMAN M, Jones DR, Wakelee H, Gao S, et al
    Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671.
    Ann Thorac Surg. 2026;121:281-289.
    PubMed     Abstract available
    
    
    
32. MURAKAMI J, Tanaka T, Shimokawa M, Yoshimine S, et al
    Probiotic Prophylaxis With Clostridium butyricum for Postoperative Infections Following Lung Resection: A Propensity Score-Weighted Analysis.
    Ann Thorac Surg. 2026;121:459-466.
    PubMed     Abstract available
    
    
    January 2026
33. MUBASHIR M
    Robotic versus Video-Assisted Thoracoscopic Surgery in Non-Small Cell Lung Cancer After Neoadjuvant Therapy: which is superior?!
    Ann Thorac Surg. 2026 Jan 29:S0003-4975(26)00087.
    PubMed    
    
    
    
34. MADEKA I, Koeneman S, Alaparthi S, Grenda T, et al
    Clinical Outcomes in Non-Small Cell Lung Cancer Among Sustained Adopters of Robotic Thoracic Surgery.
    Ann Thorac Surg. 2026 Jan 14:S0003-4975(26)00012.
    PubMed     Abstract available
    
    
    
35. MENG S, Che G
    Segmentectomy vs Lobectomy in non-small cell lung cancer patients with occult lymph node metastasis.
    Ann Thorac Surg. 2026 Jan 10:S0003-4975(26)00006.
    PubMed    
    
    
    December 2025
36. BRANDT WS
    Synchronous Primary Lung Cancer: Sequence of Therapy and Tumor Biology.
    Ann Thorac Surg. 2025 Dec 31:S0003-4975(25)01282.
    PubMed    
    
    
    
37. LI X, Li Q, Zhao E, Yang F, et al
    Perioperative Outcomes of Robotic versus Video-Assisted Thoracoscopic Surgery in Non-Small Cell Lung Cancer After Neoadjuvant Therapy.
    Ann Thorac Surg. 2025 Dec 26:S0003-4975(25)01261.
    PubMed     Abstract available
    
    
    
38. PAN H, Luo Q
    Exploring Prognostic Models and Molecular Mechanisms in Early-Stage Non-Small Cell Lung Cancer with Tumor Spread Through Air Spaces.
    Ann Thorac Surg. 2025 Dec 3:S0003-4975(25)01184.
    PubMed    
    
    
    
39. WILDER FG, Bostock IC, Watkins A, Erfe JM, et al
    Social Determinants of Health in Thoracic Surgery: Critical Points for Understanding and Implementing Change.
    Ann Thorac Surg. 2025;120:1188-1194.
    PubMed     Abstract available
    
    
    November 2025
40. CATELLI C, Guerrini S, D'Alessandro M, Mazzei MA, et al
    Lymph Node Involvement and Radiological Predictors of Invasiveness in Pure Ground-Glass Adenocarcinomas: the GORDON study.
    Ann Thorac Surg. 2025 Nov 10:S0003-4975(25)01104.
    PubMed     Abstract available
    
    
    
41. BROWNLEE AR, Perez C, Weiser L, Yu W, et al
    1121 Shape-sensing Robotic-assisted Bronchoscopic Biopsies: Diagnostic Yield and Surgical Implications.
    Ann Thorac Surg. 2025;120:928-936.
    PubMed     Abstract available
    
    
    October 2025
42. NOMURA K, Watanabe T, Takamori S, Hamada A, et al
    Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus).
    Ann Thorac Surg. 2025 Oct 30:S0003-4975(25)01059.
    PubMed     Abstract available
    
    
    
43. SEITLINGER J, Salko O, Bulgarelli Maqueda L, Meng A, et al
    Neoadjuvant chemo-immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography scan predict complete pathological response?
    Ann Thorac Surg. 2025 Oct 28:S0003-4975(25)01054.
    PubMed     Abstract available
    
    
    
44. MOONSAMY P
    Improving Lung Cancer Screening Rates is the Most Important Problem Facing Thoracic Surgeons Today.
    Ann Thorac Surg. 2025 Oct 17:S0003-4975(25)00987.
    PubMed    
    
    
    
45. WANG R, Wang Q, Xu R, Guo W, et al
    Objective Evaluation of Tubeless Thoracic Surgery in Early-stage Lung Cancer Patients Using Multi-modal Digital Device: A Prospective Study.
    Ann Thorac Surg. 2025 Oct 6:S0003-4975(25)00952.
    PubMed     Abstract available
    
    
    
46. PAN H, Tian Y, Chen H, Ge Z, et al
    Lobar versus Sub-Lobar Resection for Clinical Stage IA1-2 Non-Small Cell Lung Cancer with Tumor Spread Through Air Spaces.
    Ann Thorac Surg. 2025 Oct 4:S0003-4975(25)00909.
    PubMed     Abstract available
    
    
    
47. LEE J, Hong YS, Lee J, Lee G, et al
    Clinical N Staging Subclassification for Stage III-N2 NSCLC Patients Undergoing Trimodality Therapy: A Good Beginning Is Half the Battle.
    Ann Thorac Surg. 2025;120:665-673.
    PubMed     Abstract available
    
    
    September 2025
48. HINES SE, Dement J, Ringen K
    Occupational Risk: A Gap in Lung Cancer Screening Guidelines.
    Ann Thorac Surg. 2025 Sep 30:S0003-4975(25)00903.
    PubMed    
    
    
    
49. QU R, Fu X
    Occult N1 Non-Small Cell Lung Cancer: Why We Need Caution Before Embracing Segmentectomy as Standard.
    Ann Thorac Surg. 2025 Sep 30:S0003-4975(25)00905.
    PubMed    
    
    
    
50. WAGEMAKER VIANA S, Van Haren RM
    Bridging the Gap in Lung Cancer Screening: Lessons from a Culturally Tailored Intervention with Lay Navigators.
    Ann Thorac Surg. 2025 Sep 19:S0003-4975(25)00886.
    PubMed    
    
    
    
51. SERVAIS EL
    Defining Success in Synchronous Primary Early Lung Cancer: Recurrence Matters.
    Ann Thorac Surg. 2025 Sep 5:S0003-4975(25)00855.
    PubMed    
    
    
    
52. BRANDT WS, Rossetti NE, Eaton DB, Samson P, et al
    Synchronous Primary Early-Stage Non-Small Cell Lung Cancer: Trends in Management and Factors Associated with Improved Survival.
    Ann Thorac Surg. 2025 Sep 2:S0003-4975(25)00843.
    PubMed     Abstract available
    
    
    
53. MOTT NM, Meguid RA, Fendrick AM
    Securing Lung Cancer Screening, The First Step.
    Ann Thorac Surg. 2025 Sep 2:S0003-4975(25)00836.
    PubMed    
    
    
    August 2025
54. SEYOUM N, Eaton DB Jr, Tohmasi S, Rossetti N, et al
    Adherence to Post-Operative Survivorship Quality Metrics in Early-Stage Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2025 Aug 27:S0003-4975(25)00797.
    PubMed     Abstract available
    
    
    
55. VELOTTA JB, Burapachaisri K, Baskin AS, Zhu Z, et al
    The Importance of Lay Navigators in Lung Cancer Screening Among Asian Americans in an Integrated Healthcare System.
    Ann Thorac Surg. 2025 Aug 20:S0003-4975(25)00761.
    PubMed     Abstract available
    
    
    
56. GRIFFITH A, Pratt CG, Whitrock JN, Moore AN, et al
    Achieving Equitable Care for Racial Minority Patients with a Lung Cancer Screening Program.
    Ann Thorac Surg. 2025 Aug 12:S0003-4975(25)00749.
    PubMed     Abstract available
    
    
    
57. EZENWANKWO E
    Securing CT Lung Cancer Screening Access: Implications of the Supreme Court's Ruling in Kennedy v. Braidwood.
    Ann Thorac Surg. 2025 Aug 12:S0003-4975(25)00755.
    PubMed    
    
    
    
58. ABDALLAT M, Leo RT, Sugarbaker EA, McAllister M, et al
    Segmentectomy vs Lobectomy for Occult N1 in Non-Small Cell Lung Cancer: Is Less Still More?
    Ann Thorac Surg. 2025 Aug 8:S0003-4975(25)00725.
    PubMed     Abstract available
    
    
    
59. NG AP, Sanaiha Y, Hadaya JE, Verma A, et al
    Risk of Financial Toxicity Among Adults Undergoing Lung and Esophageal Resections for Cancer.
    Ann Thorac Surg. 2025;120:283-292.
    PubMed     Abstract available
    
    
    July 2025
60. TUPPER HI, Mendelson DS, Doo FX, Carlos RC, et al
    Imaging Interoperability: #DitchtheDisk is a Health Equity Imperative for Lung Cancer Screening & Beyond.
    Ann Thorac Surg. 2025 Jul 19:S0003-4975(25)00662.
    PubMed    
    
    
    
61. RYUKO T, Okazaki M, Mitsuhashi T, Suzawa K, et al
    Comparable Clinical Outcomes Between Segmentectomy and Lobectomy for NSCLC With Unsuspected N1/N2: A Multicenter Real-World Data Study.
    Ann Thorac Surg. 2025;120:87-98.
    PubMed     Abstract available
    
    
    
62. WEN J, Chen T, Li Y, Dong Y, et al
    Comparison of Short- and Long-term Outcomes in Patients Undergoing Sleeve Lobectomy With or Without Buttressing the Bronchial Anastomosis.
    Ann Thorac Surg. 2025;120:100-107.
    PubMed     Abstract available
    
    
    
63. OPITZ I, Lauk O, Werner R, Matter A, et al
    Characteristics of Long-term Survivors With Malignant Pleural Mesothelioma.
    Ann Thorac Surg. 2025;120:108-116.
    PubMed     Abstract available
    
    
    June 2025
64. KITAZAWA S, Bernards N, Sata Y, Yokote F, et al
    INTRAOPERATIVE SURGICAL MARGIN ASSESSMENT OF SUBLOBAR LUNG RESECTION SPECIMENS USING COMPUTED TOMOGRAPHY.
    Ann Thorac Surg. 2025 Jun 23:S0003-4975(25)00546.
    PubMed     Abstract available
    
    
    
65. HURR R, Potter AL, Jeffrey Yang CF
    Improving Lung Cancer Screening Uptake Takes a Village: The Power of Partnering with High Catchment Hospital Departments.
    Ann Thorac Surg. 2025 Jun 18:S0003-4975(25)00532.
    PubMed    
    
    
    
66. WEN J, Dong Y, Chen T, Wu J, et al
    Prognostic Impact and Recurrence Pattern of KRAS G12C Mutation in Surgically Resected Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2025 Jun 16:S0003-4975(25)00526.
    PubMed     Abstract available
    
    
    
67. RATHORE K
    Globally Recognised Difficulties in Lung Cancer Care Management That May Lead to Poor Outcomes.
    Ann Thorac Surg. 2025 Jun 16:S0003-4975(25)00527.
    PubMed    
    
    
    
68. TOMPKINS AK, Azuma M, Erkmen CP
    From Broadening to Optimizing: Refining Approach to Lung Cancer Screening Criteria.
    Ann Thorac Surg. 2025 Jun 13:S0003-4975(25)00518.
    PubMed    
    
    
    
69. REDDINGTON H, Emmerick I, Crawford A, Briskin C, et al
    Safety and Efficacy of Oncologic Second Pulmonary Resections: A Study of the Society of Thoracic Surgeons General Thoracic Surgery Database.
    Ann Thorac Surg. 2025 Jun 5:S0003-4975(25)00488.
    PubMed     Abstract available
    
    
    
70. XIE S, Hu Q, Wu Z, Wang B, et al
    Clinical and Genetic Characteristics of Early-Onset Lung Adenocarcinoma in a Large Chinese Cohort.
    Ann Thorac Surg. 2025;119:1196-1204.
    PubMed     Abstract available
    
    
    May 2025
71. WU VS, Boutros C, Bassiri A, Jiang B, et al
    Reassessing Efficacy: Understanding Failures in Lung Cancer Screening Despite Low-Dose CT Protocol Adherence.
    Ann Thorac Surg. 2025 May 28:S0003-4975(25)00448.
    PubMed     Abstract available
    
    
    
72. KHAN AA, Shah SK, Adebayo OW, Brooks C, et al
    Association Between Surgical Start Time and Major Morbidity or Mortality after Pulmonary Resection.
    Ann Thorac Surg. 2025 May 28:S0003-4975(25)00446.
    PubMed     Abstract available
    
    
    
73. LIANG H, Wang W, Zhang M, Wang R, et al
    Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer.
    Ann Thorac Surg. 2025 May 15:S0003-4975(25)00420.
    PubMed     Abstract available
    
    
    
74. KALTMAN M, Yalamanchili S, Park JA, Weyant MJ, et al
    High catchment areas for lung cancer screening-eligible patients.
    Ann Thorac Surg. 2025 May 13:S0003-4975(25)00414.
    PubMed     Abstract available
    
    
    
75. DING H, Tao B, Xu L, Jiang G, et al
    Neoadjuvant Immunochemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer with Mutations Beyond EGFR 19del, L858R, and ALK rearrangement.
    Ann Thorac Surg. 2025 May 6:S0003-4975(25)00378.
    PubMed     Abstract available
    
    
    
76. KHAN AA, Shah SK, Naeem W, Ansari M, et al
    Association Between Social Vulnerability Index and Time-to-Treatment in Resectable Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2025 May 6:S0003-4975(25)00380.
    PubMed     Abstract available
    
    
    
77. LAM GT
    Medicaid Expansion and Regionalization of Lung Cancer Surgery: A Double-Edged Sword?
    Ann Thorac Surg. 2025 May 2:S0003-4975(25)00374.
    PubMed    
    
    
    
78. WOODARD GA, Grau-Sepulveda M, Onaitis MW, Udelsman BV, et al
    Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation.
    Ann Thorac Surg. 2025;119:1071-1081.
    PubMed     Abstract available
    
    
    April 2025
79. ORTIZ BA, Engrav SK, Roden AC, Boland JM, et al
    Impact of frozen section pathology examination of surgical margins in sublobar pulmonary resections for clinical stage IA NSCLC.
    Ann Thorac Surg. 2025 Apr 25:S0003-4975(25)00338.
    PubMed     Abstract available
    
    
    
80. HOODA Z, Duan Z, Ries S, Antonoff MB, et al
    Association of Medicaid Expansion With Timely Treatment and Access to High-Volume Hospitals in Early-Stage Lung Cancer Patients.
    Ann Thorac Surg. 2025 Apr 11:S0003-4975(25)00321.
    PubMed     Abstract available
    
    
    
81. CHEN J, Zhao ZR, Deng H, Yang C, et al
    Extended sleeve lobectomy after neoadjuvant immunochemotherapy for centrally located non-small cell lung cancer.
    Ann Thorac Surg. 2025 Apr 9:S0003-4975(25)00298.
    PubMed     Abstract available
    
    
    
82. VANWINKLE CK, Fu W, Hassett KP, Thompson MP, et al
    The Association between Participation in a Quality Collaborative and Value in Lung Cancer Surgery.
    Ann Thorac Surg. 2025 Apr 5:S0003-4975(25)00295.
    PubMed     Abstract available
    
    
    
83. RUSCH VW
    An unresolved surgical conundrum: How to manage unsuspected nodal involvement in early-stage lung cancer.
    Ann Thorac Surg. 2025 Apr 2:S0003-4975(25)00282.
    PubMed    
    
    
    March 2025
84. SHAH SK, Khan AA, Basu S, Seder CW, et al
    Minimally Invasive Pneumonectomy vs Open Pneumonectomy: Outcomes and Predictors of Conversion.
    Ann Thorac Surg. 2025;119:634-642.
    PubMed     Abstract available
    
    
    
85. EISENBERG M, Deboever N, Hofstetter WL, Mehran RJ, et al
    Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough?
    Ann Thorac Surg. 2025;119:616-624.
    PubMed     Abstract available
    
    
    February 2025
86. VERGE R, Rouch A, Rabinel P, Renaud C, et al
    Evaluation of uncertain resection for localized non-small cell lung cancer: the crucial prognosis of suboptimal lymph node assessment.
    Ann Thorac Surg. 2025 Feb 27:S0003-4975(25)00170.
    PubMed     Abstract available
    
    
    
87. FARINA JM, D'Cunha J
    Sorting Out the Pieces of Fragmented Lung Cancer Care.
    Ann Thorac Surg. 2025 Feb 19:S0003-4975(25)00120.
    PubMed    
    
    
    
88. CROSINA J, Wright F, Irish J, Rashid M, et al
    Long-Term Impact of Regionalization of Thoracic Oncology Surgery.
    Ann Thorac Surg. 2025;119:460-469.
    PubMed     Abstract available
    
    
    
89. RESIO BJ, Tan KS, Skovgard M, Dycoco J, et al
    Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection.
    Ann Thorac Surg. 2025;119:308-315.
    PubMed     Abstract available
    
    
    
90. HUANG L, Petersen RH
    Impact of Margin Distance on Locoregional Recurrence and Survival After Thoracoscopic Segmentectomy.
    Ann Thorac Surg. 2025;119:316-324.
    PubMed     Abstract available
    
    
    
91. HAYANGA JWA, Luo X, Hasasna I, Rothenberg P, et al
    Intersection of Race, Rurality, and Income in Defining Access to Minimally Invasive Lung Surgery.
    Ann Thorac Surg. 2025;119:325-332.
    PubMed     Abstract available
    
    
    January 2025
92. KAMTAM DN, Berry MF, Lin N, Kapula N, et al
    The association of chylothorax with aggressiveness of lymph node management during pulmonary resection.
    Ann Thorac Surg. 2025 Jan 31:S0003-4975(25)00086.
    PubMed     Abstract available
    
    
    
93. POTTER AL, Guo Q, Srinivasan D, Yang ME, et al
    Assessing Lung Cancer Screening Eligibility of Lung Cancer Patients in the Boston Lung Cancer Study: An Analysis of 7,186 Lung Cancer Cases.
    Ann Thorac Surg. 2025 Jan 21:S0003-4975(25)00067.
    PubMed     Abstract available
    
    
    
94. ANTONOFF MB, Mitchell KG, Kim SS, Salfity HV, et al
    The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer.
    Ann Thorac Surg. 2025 Jan 9:S0003-4975(24)00960.
    PubMed     Abstract available
    
    
    
95. KRANTZ SB, Mitzman B, Antonoff MB, Backhus L, et al
    Thoracic Surgery Outcomes Research Network (ThORN) Consensus Document on Defining a High Quality Wedge Resection for Early Stage Lung Cancer.
    Ann Thorac Surg. 2025 Jan 8:S0003-4975(25)00004.
    PubMed     Abstract available
    
    
    
96. MIMAE T, Miyata Y, Tsubokawa N, Kudo Y, et al
    Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors.
    Ann Thorac Surg. 2025;119:192-198.
    PubMed     Abstract available
    
    
    December 2024
97. STUART CM, Mott NM, Bronsert MR, Randhawa SK, et al
    The Association between Sociodemographic Factors and Delays to Minimally Invasive Surgery for Stage IA-IIIA Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Dec 24:S0003-4975(24)01115.
    PubMed     Abstract available
    
    
    
98. MATSUDO K, Takada K, Kinoshita F, Hashinokuchi A, et al
    CD155 Expression in Early-Stage Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;118:1197-1205.
    PubMed     Abstract available
    
    
    November 2024
99. HOODA Z, Antonoff MB
    Using Lung Cancer Screening To Treat the Whole Patient, Not the Disease.
    Ann Thorac Surg. 2024 Nov 27:S0003-4975(24)01017.
    PubMed    
    
    
    
100. AL-THANI S, Nasar A, Villena-Vargas J, Chow O, et al
     Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer
     Ann Thorac Surg. 2024 Nov 13:S0003-4975(24)00957.
     PubMed     Abstract available
     
     
     
101. ODEH A, Verm R, Park S, Swanson J, et al
     Fragmented care, Commission on Cancer Accreditation and Overall Survival in Patients Receiving Surgery and Chemotherapy for Lung Cancer.
     Ann Thorac Surg. 2024 Nov 11:S0003-4975(24)00940.
     PubMed     Abstract available
     
     
     
102. LANUTI M
     What Is Best Liquid Remnant for Resected Early-Stage Non-small Cell Lung Cancer?
     Ann Thorac Surg. 2024;118:1144-1145.
     PubMed    
     
     
     October 2024
103. ELY S, Osarogiagbon RU
     Metrics for Benchmarking Lung Cancer Surgery Quality: Not waiting for Godot!
     Ann Thorac Surg. 2024 Oct 29:S0003-4975(24)00924.
     PubMed    
     
     
     
104. HOODA Z, Antonoff MB
     Less is More-Further Evidence Favoring Segmentectomy for Clinical Stage IA Lung Cancer.
     Ann Thorac Surg. 2024 Oct 25:S0003-4975(24)00882.
     PubMed    
     
     
     
105. LI Z, Wu L, Wang C, Wang S, et al
     Outcomes after neoadjuvant therapy with/without immunotherapy followed by pneumonectomy in non-small cell lung cancer patients.
     Ann Thorac Surg. 2024 Oct 25:S0003-4975(24)00879.
     PubMed     Abstract available
     
     
     
106. D'ANDRILLI A, Marinucci BT, Ciccone AM, Ibrahim M, et al
     CARINAL RECONSTRUCTION FOR LUNG CANCER AND AIRWAY TUMORS: LONG-TERM RESULTS.
     Ann Thorac Surg. 2024 Oct 22:S0003-4975(24)00876.
     PubMed     Abstract available
     
     
     
107. RICE D, Singhal S, Niemeyer E, Sarkaria I, et al
     Intraoperative Molecular Imaging with Pafolacianine in Resection of Occult Pulmonary Malignancy in the ELUCIDATE trial.
     Ann Thorac Surg. 2024 Oct 21:S0003-4975(24)00869.
     PubMed     Abstract available
     
     
     
108. LI X, Li Q, Yang F, Gao E, et al
     Survival Outcomes of Neoadjuvant Therapy Followed by Sleeve Lobectomy in Non-Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Oct 17:S0003-4975(24)00863.
     PubMed     Abstract available
     
     
     
109. KIM SS, Cooke DT, Kidane B, Tapias LF, et al
     The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Oct 16:S0003-4975(24)00861.
     PubMed     Abstract available
     
     
     
110. RUSCH VW
     Sublobar Resection for Subsolid Lung Adenocarcinomas: How Much Margin Is Enough?
     Ann Thorac Surg. 2024;118:810.
     PubMed    
     
     
     
111. GROTH SS
     Unraveling the Association Between Size of Lepidic-Predominant Adenocarcinomas and the Risk of Nodal Metastasis.
     Ann Thorac Surg. 2024;118:823-824.
     PubMed    
     
     
     
112. KAMTAM DN, Berry MF, Lui NS, Satoyoshi M, et al
     What Is an Adequate Margin During Sublobar Resection of
     Ann Thorac Surg. 2024;118:801-809.
     PubMed     Abstract available
     
     
     
113. SI H, Xu L, Zhao Y, Su H, et al
     Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma.
     Ann Thorac Surg. 2024;118:825-833.
     PubMed     Abstract available
     
     
     
114. WONG LY, Elliott IA, Liou DZ, Backhus LM, et al
     Lepidic-Type Lung Adenocarcinomas: Is It Safe to Observe for Growth Before Treating?
     Ann Thorac Surg. 2024;118:817-823.
     PubMed     Abstract available
     
     
     September 2024
115. XU R, Miao P
     Public health and social work collaborative rehabilitation assessment of different lung cancer resection.
     Ann Thorac Surg. 2024 Sep 20:S0003-4975(24)00825.
     PubMed    
     
     
     
116. BROWNLEE AR
     When a Lung Nodule Program Becomes Self-Aware.
     Ann Thorac Surg. 2024;118:718-719.
     PubMed    
     
     
     
117. KRANTZ SB, Su KW
     More for More's Sake Alone? Completion Lobectomy in the Setting of Occult Nodal Disease.
     Ann Thorac Surg. 2024;118:663-664.
     PubMed    
     
     
     
118. HEADRICK JR JR, Parker MJ, Miller AD
     Artificial Intelligence: Can It Save Lives, Hospitals, and Lung Screening?
     Ann Thorac Surg. 2024;118:712-718.
     PubMed     Abstract available
     
     
     
119. KNEUERTZ PJ
     Real-World Experience Favors a Neoadjuvant Strategy of Chemoimmunotherapy for Locoregionally Advanced NSCLC.
     Ann Thorac Surg. 2024;118:681-682.
     PubMed    
     
     
     
120. MARTIN JL, Mack SJ, Rshaidat H, Collins ML, et al
     Wedge Resection Outcomes: A Comparison of Video-Assisted and Robot-Assisted Wedge Resections.
     Ann Thorac Surg. 2024;118:683-690.
     PubMed     Abstract available
     
     
     August 2024
121. BROWN LM, Bonnell L, Parsons N, Cooke DT, et al
     Predictors of Discharge with Supplemental Oxygen after Lobectomy for Lung Cancer.
     Ann Thorac Surg. 2024 Aug 28:S0003-4975(24)00693.
     PubMed     Abstract available
     
     
     
122. MCALLISTER MA, Herrera-Zamora J, Barcelos RR, Leo R, et al
     Left Upper Lobectomy versus Trisegmentectomy for Lung Cancer: A Propensity-Score Matched Comparison.
     Ann Thorac Surg. 2024 Aug 26:S0003-4975(24)00684.
     PubMed     Abstract available
     
     
     
123. TONG BC, Bonnell LN, Habib RH, Shahian DM, et al
     The STS 2024 Risk Models for Lung Cancer Resection: Continued Refinement and Improved Outcomes.
     Ann Thorac Surg. 2024 Aug 26:S0003-4975(24)00686.
     PubMed     Abstract available
     
     
     
124. ROSSETTI NE, Eaton DB Jr, Tohmasi S, Heiden BT, et al
     Early-stage lung cancer in the era of lung cancer screening: VA outperforms other insurance models.
     Ann Thorac Surg. 2024 Aug 21:S0003-4975(24)00678.
     PubMed     Abstract available
     
     
     
125. MITZMAN B
     The Entire NSCLC Spectrum: No Cancer Left Behind.
     Ann Thorac Surg. 2024;118:393-394.
     PubMed    
     
     
     
126. DAI J, Sun F, Bao M, Cao J, et al
     Pulmonary Function Recovery and Displacement Patterns After Anatomic Segmentectomy vs Lobectomy.
     Ann Thorac Surg. 2024;118:365-374.
     PubMed     Abstract available
     
     
     
127. CAMPISI A, Dell'Amore A, Faccioli E, Fang W, et al
     A Multicenter Retrospective Case-Control Study on Simple vs Extended Sleeve Lobectomies.
     Ann Thorac Surg. 2024;118:375-383.
     PubMed     Abstract available
     
     
     
128. WAN S, Shen Z, Hu S, Zhang L, et al
     Spread Through Air Spaces in Stage I Pulmonary Large Cell Neuroendocrine Carcinoma.
     Ann Thorac Surg. 2024;118:385-393.
     PubMed     Abstract available
     
     
     July 2024
129. RUSCH VW
     Surgical Resection for Pleural Mesothelioma: Is It All About Patient Selection?
     Ann Thorac Surg. 2024;118:223-224.
     PubMed    
     
     
     
130. NAKAMURA A, Hashimoto M, Kuroda A, Matsumoto S, et al
     Impact of Operation on Disease Progression and Survival of Patients With Pleural Mesothelioma.
     Ann Thorac Surg. 2024;118:216-223.
     PubMed     Abstract available
     
     
     
131. KAGIMOTO A, Ishida M, Mimura T
     Significance of the Goddard Score in Predicting Complications Related to Air Leak After Lobectomy.
     Ann Thorac Surg. 2024;118:233-239.
     PubMed     Abstract available
     
     
     June 2024
132. WONG LY, Dale R, Kapula N, Elliott IA, et al
     Impacts of Positive Margins and Surgical Extent on Outcomes after Early-Stage Lung Cancer Resection.
     Ann Thorac Surg. 2024 Jun 10:S0003-4975(24)00460.
     PubMed     Abstract available
     
     
     
133. NOBEL TB, Tan KS, Adusumilli PS, Bains MS, et al
     Outcomes of Patients Undergoing Segmentectomy for Occult Node-Positive Clinical Stage IA Lung Cancer.
     Ann Thorac Surg. 2024 Jun 10:S0003-4975(24)00448.
     PubMed     Abstract available
     
     
     
134. BRIBRIESCO A
     Aim Local, Expect Global-EGFR and Recurrence in Stage I Lung Adenocarcinoma.
     Ann Thorac Surg. 2024;117:1119-1120.
     PubMed    
     
     
     
135. YANG F, Sun K, Li F, Li X, et al
     The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.
     Ann Thorac Surg. 2024;117:1111-1119.
     PubMed     Abstract available
     
     
     May 2024
136. BOU-SAMRA P, Kennedy GT, Chang A, Guo E, et al
     Phase 2 Trial of VGT-309: Cathepsin-Based Near-Infrared Probe for Intraoperative Molecular Imaging.
     Ann Thorac Surg. 2024 May 30:S0003-4975(24)00396.
     PubMed     Abstract available
     
     
     
137. SAWABATA N, Hamaji M, Yoshikawa D, Miyata R, et al
     Clustered circulating tumor cells as a predictor of adjuvant-chemotherapy efficacy in lung cancer.
     Ann Thorac Surg. 2024 May 22:S0003-4975(24)00379.
     PubMed     Abstract available
     
     
     
138. RUSCH VW
     Wedge Resection Versus Segmentectomy for Clinical Stage IA Non-small Cell Lung Cancer: Are They Truly Oncologically Equivalent?
     Ann Thorac Surg. 2024 May 9:S0003-4975(24)00359.
     PubMed    
     
     
     April 2024
139. TAKAHASHI T
     Study-design of adjuvant chemotherapy for lung cancer: A cart before the horse.
     Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00285.
     PubMed    
     
     
     
140. SHAHZAD MH, Spicer JD, Rusch VW, Kneuertz PJ, et al
     Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer - Current Evidence and Future Directions.
     Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00280.
     PubMed     Abstract available
     
     
     
141. BLASBERG JD, Li A
     Evening the Odds: Making 1 + 1 = 2 for Bilobectomy.
     Ann Thorac Surg. 2024;117:874-875.
     PubMed    
     
     
     
142. KAMIGAICHI A, Mimae T, Tsubokawa N, Miyata Y, et al
     Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.
     Ann Thorac Surg. 2024;117:743-751.
     PubMed     Abstract available
     
     
     March 2024
143. TOWE CW, Grau-Sepulveda MV, Hartwig MG, Kang L, et al
     STS Database Analysis: Comparing Sublobar Techniques in Stage IA Lung Cancer.
     Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00191.
     PubMed     Abstract available
     
     
     
144. FERRARIS VA
     Venous Thromboembolism as Postoperative Complication Following Lung Cancer Operations.
     Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00188.
     PubMed    
     
     
     
145. STILES BM, Rodriguez-Quintero JH
     A "Solid" Rationale for Lymphadenectomy in Small, Peripheral Lung Cancers.
     Ann Thorac Surg. 2024;117:593.
     PubMed    
     
     
     February 2024
146. ALDERETE IS, Nakata K, Hartwig MG
     Overcoming Hesitancy: Embracing Extended Sleeve Lobectomy for Advanced Non-Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00120.
     PubMed    
     
     
     
147. PONTULA A, Spies CS, Hartwig MG
     Incidentally Found Lung Cancer Following Lung Transplantation: Apples and Oranges.
     Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00118.
     PubMed    
     
     
     
148. DUNNE EG, Fick CN, Isbell JM, Chaft JE, et al
     The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Feb 3:S0003-4975(24)00080.
     PubMed     Abstract available
     
     
     
149. YOUNG AM, Viktorsson SA, Strobel RJ, Rotar EP, et al
     Five-Year Sustained Impact of a Thoracic Enhanced Recovery After Surgery Program.
     Ann Thorac Surg. 2024;117:422-430.
     PubMed     Abstract available
     
     
     
150. FERRARI-LIGHT D, Kneuertz PJ
     Life in the Fast Lane: Rapid Discharge After Minimally Invasive Anatomic Lung Resection Is Feasible and Safe.
     Ann Thorac Surg. 2024;117:303-304.
     PubMed    
     
     
     January 2024
151. COSTER JN, Sanchez PG
     Surviving Incidentally Found Non-Small Cell Lung Cancer After Lung Transplantation.
     Ann Thorac Surg. 2024 Jan 27:S0003-4975(24)00071.
     PubMed    
     
     
     
152. FONG AJ, Reich H, Mirocha J, Wong A, et al
     Disparities and Underutilization of Surgery for Early Stage Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Jan 26:S0003-4975(24)00067.
     PubMed     Abstract available
     
     
     
153. AXTELL AL, Gaissert HA, Bao X, Auchincloss HG, et al
     Predictors of Venous Thromboembolism after Lung Cancer Resection.
     Ann Thorac Surg. 2024 Jan 25:S0003-4975(24)00014.
     PubMed     Abstract available
     
     
     
154. MARTINS RS, Razi SS, Alnajar A, Poulikidis K, et al
     Neoadjuvant versus Adjuvant Chemoimmunotherapy for Stage II-IIIB Non-Small Cell Lung Cancer.
     Ann Thorac Surg. 2024 Jan 19:S0003-4975(24)00013.
     PubMed     Abstract available
     
     
     
155. POTTER AL, Senthil P, Keshwani A, McCleery S, et al
     Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial.
     Ann Thorac Surg. 2024 Jan 10:S0003-4975(24)00004.
     PubMed     Abstract available
     
     
     
156. MIMAE T, Miyata Y, Tsubokawa N, Shimada Y, et al
     Sublobar resection in early non-small cell lung cancer with epidermal growth factor receptor mutant.
     Ann Thorac Surg. 2024 Jan 8:S0003-4975(24)00002.
     PubMed     Abstract available
     
     
     
157. KNEUERTZ PJ, Ferrari-Light D, Altorki NK
     Sublobar Resection vs Lobectomy for Stage IA Non-Small Cell Lung Carcinoma-Takeaways From Modern Randomized Trials.
     Ann Thorac Surg. 2024 Jan 5:S0003-4975(24)00001.
     PubMed     Abstract available
     
     
     
158. LI AX, Canavan ME, Ermer T, Maduka RC, et al
     Respect the Middle Lobe: Perioperative Risk of Bilobectomy Compared With Lobectomy and Pneumonectomy.
     Ann Thorac Surg. 2024;117:163-171.
     PubMed     Abstract available
     
     
     November 2023
159. COLLINS ML, Mack SJ, Whitehorn GL, Till BM, et al
     Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States.
     Ann Thorac Surg. 2023 Nov 21:S0003-4975(23)01165.
     PubMed     Abstract available
     
     
     
160. YUN T, Zhang Y, Liu A, Qin Y, et al
     Randomized Trial of Modified Chest Tube Placement vs Routine Placement After Lung Resection.
     Ann Thorac Surg. 2023;116:1013-1019.
     PubMed     Abstract available
     
     
     
161. ROSENSTEIN AL, Potter AL, Senthil P, Raman V, et al
     The Role of Salvage Resection After Definitive Radiation Therapy for Non-small Cell Lung Cancer.
     Ann Thorac Surg. 2023;116:997-1003.
     PubMed     Abstract available
     
     
     
162. ZHOU N, Niu J, Nelson D, Feldman HA, et al
     Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection.
     Ann Thorac Surg. 2023;116:1020-1027.
     PubMed     Abstract available
     
     
     October 2023
163. MORKVED AL, Sogaard M, Skjoth F, Ording AG, et al
     Risk and timing of venous thromboembolism after surgery for lung cancer: a nationwide cohort study.
     Ann Thorac Surg. 2023 Oct 25:S0003-4975(23)01073.
     PubMed     Abstract available
     
     
     
164. RSHAIDAT H, Okusanya OT
     Using the Ultimate Lung Biopsy.
     Ann Thorac Surg. 2023;116:701-702.
     PubMed    
     
     
     September 2023
165. RUSCH VW
     Process improvement in lymphadenectomy for lung cancer: The wave of the future?
     Ann Thorac Surg. 2023 Sep 15:S0003-4975(23)00958.
     PubMed    
     
     
     
166. SPIES CS, Ochoa TN, Pontula A, Harris CS, et al
     With Comparable Outcomes, Should Early Stage Lung Cancer Be A Contraindication to Lung Transplant?
     Ann Thorac Surg. 2023 Sep 11:S0003-4975(23)00934.
     PubMed     Abstract available
     
     
     
167. OSAROGIAGBON RU, Ray MA, Fehnel C, Akinbobola O, et al
     Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.
     Ann Thorac Surg. 2023 Sep 5:S0003-4975(23)00927.
     PubMed     Abstract available
     
     
     August 2023
168. POTTER AL, Spasojevic A, Raman V, Hurd JC, et al
     The Increasing Adoption of Minimally Invasive Lobectomy in the United States.
     Ann Thorac Surg. 2023;116:222-229.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum